This long-term follow-up study of the B-PROOF trial assessed the impact of daily supplementation with folic acid (400 μg) and vitamin B12 (500 μg) on cancer incidence among 2,524 older adults over 2–3 years. The findings revealed a 25% increased risk of overall cancer (HR 1.25; 95% CI, 1.00–1.53; P
